Cardiovascular drug-drug interactions.

Area of Science:

• Pharmacology
• Cardiovascular Medicine
• Clinical Pharmacy

Background:

• Drug-drug interactions (DDIs) pose significant clinical challenges, particularly for patients with cardiovascular disease.
• Predicting DDIs is complex due to interpatient variability in drug metabolism and disposition.
• Despite challenges, some DDIs can be anticipated and managed with clinical expertise.

Purpose of the Study:

• To highlight the clinical relevance of documented and suspected drug-drug interactions in cardiovascular disease management.
• To emphasize the importance of clinician knowledge in mitigating adverse drug events.
• To provide a foundation for understanding and managing DDIs.

Main Methods:

• Review of documented and suspected drug-drug interactions relevant to cardiovascular patients.
• Discussion of pharmacokinetic and pharmacodynamic principles influencing drug interactions.
• Emphasis on clinical judgment and knowledge-based avoidance strategies.

Main Results:

• Drug-drug interactions are common and clinically relevant in cardiovascular patient care.
• Interpatient variability complicates the prediction of drug interactions.
• Knowledge of drug interactions and pharmacokinetic/pharmacodynamic principles aids in risk management.

Conclusions:

• Clinicians must maintain current knowledge of drug-drug interactions affecting cardiovascular patients.
• Understanding pharmacokinetic and pharmacodynamic principles is essential for predicting and minimizing DDIs.
• Proactive management through clinical judgment can reduce the incidence and severity of DDIs in cardiovascular medicine.